Fact CheckerSign in

NCT07913802Recruiting

Prospective Multicenter Cohort Study of Clinical and Molecular Biomarkers in Colorectal Cancer

Prospective Cohort Study to Investigate Clinical Factors and Molecular Biomarkers Associated With Treatment Response and Disease Outcomes in Patients With Colorectal Cancer in Vorarlberg, Austria

Source: ClinicalTrials.gov · Last updated 3 Nov 2026

Brief summary (registry, in English)

This prospective, multicenter observational study aims to identify clinical and molecular biomarkers associated with treatment response, disease recurrence, progression, and survival in patients with colorectal cancer (CRC). Approximately 200 adult patients undergoing surgical resection for CRC will be enrolled and followed for up to five years. Tumor tissue and blood samples will be collected for molecular analyses, and clinical data will be recorded longitudinally to investigate associations between biomarkers and disease outcomes. All treatment decisions will follow standard clinical practice and will not be influenced by study participation.

Status (registry)
Recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
28 Oct 2026
Start date
23 Oct 2023
Primary completion date
31 Oct 2028
Lead sponsor
Vorarlberg Institute for Vascular Investigation and Treatment
NCT number
NCT07913802

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 23 Oct 2023 to the primary completion date, 31 Oct 2028
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Known current alcohol and/or illicit drug abuse that, in the investigator's judgment, may compromise participant safety and/or compliance.

Age

  • Age \<18 years.

Other

  • Pregnancy.
  • Individuals held in custody by order of a court or public authority.
  • Inability to understand and sign the informed consent form.

Who the study is looking for

  • Age ≥18 years.
  • Histologically confirmed colorectal carcinoma.
  • Planned surgical resection of the primary colorectal tumor.
  • Written informed consent to participate in the study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Landeskrankenhaus Bregenz
Coordinator of this site? Confirm its status
BregenzAustriaRecruiting
Landeskrankenhaus Feldkirch
Coordinator of this site? Confirm its status
FeldkirchAustriaRecruiting
Landeskrankenhaus Hohenems
Coordinator of this site? Confirm its status
HohenemsAustriaActive, not recruiting
Landeskrankenhaus Rankweil
Coordinator of this site? Confirm its status
RankweilAustriaActive, not recruiting

This page is information, not medical advice. Discuss any trial with your doctor.